BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

Impact · against what's priced in

BDX receives a net positive catalyst from a landmark U.S. government partnership that secures relief from future Section 232 tariffs, protecting gross margins. While expanded domestic manufacturing will likely increase CapEx and pressure short-term free cash flow, the long-term supply chain resilience and trade protections provide structural upside.

BDX+0.60

No priced-in read yet